Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

450 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efavirenz pharmacokinetics during the third trimester of pregnancy and postpartum.
Cressey TR, Stek A, Capparelli E, Bowonwatanuwong C, Prommas S, Sirivatanapa P, Yuthavisuthi P, Neungton C, Huo Y, Smith E, Best BM, Mirochnick M; IMPAACT P1026s Team. Cressey TR, et al. Among authors: capparelli e. J Acquir Immune Defic Syndr. 2012 Mar 1;59(3):245-52. doi: 10.1097/QAI.0b013e31823ff052. J Acquir Immune Defic Syndr. 2012. PMID: 22083071 Free PMC article. Clinical Trial.
Pharmacokinetics and tolerance of zidovudine in preterm infants.
Capparelli EV, Mirochnick M, Dankner WM, Blanchard S, Mofenson L, McSherry GD, Gay H, Ciupak G, Smith B, Connor JD; Pediatric AIDS Clinical Trials Group 331 Investigators. Capparelli EV, et al. J Pediatr. 2003 Jan;142(1):47-52. doi: 10.1067/mpd.2003.mpd0335. J Pediatr. 2003. PMID: 12520254 Clinical Trial.
Pharmacokinetics of antiretrovirals in pregnant women.
Mirochnick M, Capparelli E. Mirochnick M, et al. Among authors: capparelli e. Clin Pharmacokinet. 2004;43(15):1071-87. doi: 10.2165/00003088-200443150-00002. Clin Pharmacokinet. 2004. PMID: 15568888 Review.
Pharmacotherapy of perinatal HIV.
Capparelli E, Rakhmanina N, Mirochnick M. Capparelli E, et al. Semin Fetal Neonatal Med. 2005 Apr;10(2):161-75. doi: 10.1016/j.siny.2004.10.001. Epub 2005 Jan 20. Semin Fetal Neonatal Med. 2005. PMID: 15701581 Review.
Persistence of nevirapine exposure during the postpartum period after intrapartum single-dose nevirapine in addition to zidovudine prophylaxis for the prevention of mother-to-child transmission of HIV-1.
Cressey TR, Jourdain G, Lallemant MJ, Kunkeaw S, Jackson JB, Musoke P, Capparelli E, Mirochnick M. Cressey TR, et al. Among authors: capparelli e. J Acquir Immune Defic Syndr. 2005 Mar 1;38(3):283-8. J Acquir Immune Defic Syndr. 2005. PMID: 15735445 Clinical Trial.
Pharmacokinetics of didanosine and drug resistance mutations in infants exposed to zidovudine during gestation or postnatally and treated with didanosine or zidovudine in the first three months of life.
Kovacs A, Cowles MK, Britto P, Capparelli E, Fowler MG, Moye J, McIntosh K, Rathore MH, Pitt J, Husson RN. Kovacs A, et al. Among authors: capparelli e. Pediatr Infect Dis J. 2005 Jun;24(6):503-9. doi: 10.1097/01.inf.0000164787.63237.0b. Pediatr Infect Dis J. 2005. PMID: 15933559 Clinical Trial.
Immune reconstitution after receipt of highly active antiretroviral therapy in children with advanced or progressive HIV disease and complete or partial viral load response.
Kovacs A, Montepiedra G, Carey V, Pahwa S, Weinberg A, Frenkel L, Capparelli E, Mofenson L, Smith E, McIntosh K, Burchett SK; Pediatric AIDS Clinical Trials Group 366 Study Team. Kovacs A, et al. Among authors: capparelli e. J Infect Dis. 2005 Jul 15;192(2):296-302. doi: 10.1086/430922. Epub 2005 Jun 14. J Infect Dis. 2005. PMID: 15962224 Clinical Trial.
450 results